Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization
- 15 May 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (10), 1419-1426
- https://doi.org/10.1086/587695
Abstract
Background. Whether hepatitis B (HB) vaccine-conferred immunity persists into adulthood is unknown. We aimed to investigate long-term HB immunity in adolescents.Keywords
This publication has 33 references indexed in Scilit:
- Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future StrategiesGastroenterology, 2007
- Seroprevalence of Hepatitis‐B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis‐B vaccination programJournal of Medical Virology, 2006
- Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccinationHepatology, 2004
- Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B VaccinationAnnals of Internal Medicine, 2001
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenThe New England Journal of Medicine, 1997
- The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothersThe Pediatric Infectious Disease Journal, 1991
- Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothersJAMA, 1988
- A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothersJAMA, 1987
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983
- Immunogenicity of Hepatitis B Virus Vaccine in Healthy Chinese NeonatesThe Journal of Infectious Diseases, 1983